Alpenglow Biosciences

Seattle, WA · Founded 2018 · Privately Held (backing)

Developer of a microscopy imaging system designed to analyze images of complex and morphological structures of tissue samples. Alpenglow Biosciences is based in Seattle, WA and was founded in 2018. Its last reported valuation was $14.6 million in Jun 2021. It has raised $9.8 million across 1 recorded round; the latest was a $3 million seed round in Mar 2024.

Last reported valuation
$14.6M
Oct 2026
Priced at
—
Total raised
$9.8M
Last round
Seed Round
Mar 2024

Who backs Alpenglow Biosciences?

12 investors
InvestorType
Creative Destruction LabOther
National Institutes of HealthOther
Mayo ClinicOther
WRF CapitalOther
Alexandria Real Estate Equities—
Andy Hill Care Fund—
Dynamk Capital—
First In Ventures—
Hamamatsu Corporate Venture Capital—
U.S. Department of Health and Human Services—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Alpenglow Biosciences investors

12 investors are on record for Alpenglow Biosciences, including Creative Destruction Lab, National Institutes of Health, Mayo Clinic and WRF Capital. The seed round in Mar 2024 drew 14 investors.

Free account
More of Alpenglow Biosciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch Alpenglow Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Alpenglow Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View